Trial intelligence / Profile preview

Lomaira for parents of obese toddlers

NCT06768320Phase 4Withdrawn

Sponsor
Loma Linda University
Start
Dec 2025
Primary completion
Jan 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of phentermine in obesity, sponsored by Loma Linda University. Planned start Dec 2025; status: withdrawn.

02

Drugs

phentermine
03

Conditions

obesity

Beyond the preview

Go deeper on NCT06768320.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06768320.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call